NandrolonePhenylproprionate is chemically related to the male
hormone. Compared to testosterone, it has an enhanced anabolic and a
reduced androgenic activity. This has been demonstrated in animal
bioassays and explained by receptor binding studies. The low
androgenicity of nandrolone is confirmed in clinical use. In the human,
nandrolone has been shown to positively influence calcium metabolism and
to increase bone mass in osteoporosis. In women with disseminated
mammary carcinoma, Nandrolone has been reported to produce objective
regressions for many months. Furthermore, Nandrolone has a
nitrogen-saving action. This effect on protein metabolism has been
established by metabolic studies and is utilised therapeutically in
conditions where a protein deficiency exists such as during chronic
debilitating diseases and after major surgery and severe trauma. In
these conditions, Nandrolone Phenylpropionate serves as a supportive
adjunct to specific therapies and dietary measures as well as parenteral
nutrition, due to it's faster acting nature Nandrolone phenylpropionate
is preffered in situations where a faster clinical response is required
over it's chemical variant Nandrolone decaonate.
